References
- Griner PF, Mayewski RJ, Mushlin Al, et al. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med 1981: 94(4 Pt 2): 557–92
- Jeffery MS, Dick WC, eds. The role of the laboratory in rheumatology. Clin Rheum Dis 1983: 9(Apr): 1–288
- Kelley WN, Harris ED Jr, Ruddy S, et al, eds. Textbook of rheumatology. Philadelphia: WB Saunders. 1980
- Stewart SR, Gershwin ME. Diagnostic tests and procedures in rheumatic diseases. In: Halsted CH, Halsted JA, eds. The laboratory in clinical medicine: interpretation and application. 2nd ed. Philadelphia: WB Saunders. 1981: 565–611
- Healey LA, Croft JD, Epstein WV, et al. Guidelines for rheumatic disease management. Bull Rheum Dis 1981: 31: 11–4
- Lawrence RC, Shulman LE, eds. Current topics in rheumatology, epidemiology of the rheumatic diseases. Proceedings of the Fourth International Conference. National Institutes of Health. New York: Gower Medical Publishing. 1984
- Cebul RD, Hershey JC, Williams SV. Using multiple tests: series and parallel approaches. Clin Lab Med 1982: 2(4): 871–90
- Mallya RK, de Beer FC, Berry H, et al. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982: 9(2): 224–8
- Fries JF, Weyl S, Holman HR. Estimating prognosis in systemic lupus erythematosus. Am J Med 1974: 57(4): 561–5
- Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (Pentaxins) and serum amyloid A protein. Adv Immunol 1983: 34: 141–212
- Tan EM. Antinuclear antibodies in diagnosis and management. Hosp Pract 1983: 18(1): 79–84
- Ginsburg WW, Conn DL, Bunch TW, et al. Comparison of clinical and serologic markers in systemic lupus erythematosus and overlap syndrome: a review of 247 patients. J Rheumatol 1983: 10(2): 235–41
- Davis P, Christian B, Russell AS. Immunofluorescent technique for detection of antibodies to n-DNA: comparison with radioimmunoassay. J Rheumatol 1977: 4(1): 15–20
- Eaton RB, Schnneider G, Schur PH. Enzyme immunoassay for antibodies to native DNA: specificity and quality of antibodies. Arthritis Rheum 1983: 26(1): 52–62
- Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1968: 278(Mar 7): 533–8
- Whiting-O'Keefe Q, Henke JE, Shearn MA, et al. The information content from renal biopsy in systemic lupus erythematosus. Ann Intern Med 1982: 96(6 Pt 1): 718–23
- Cooper NR, Nemerow GR, Mayes JT. Methods to detect and quantitate complement activation. Springer Semin Immunopathol 1983: 6(Sep): 195–212
- Bisno AL, Ofek I. Serologic diagnosis of streptococcal infection: comparison of a rapid hemagglutination technique with conventional antibody tests. Am J Dis Child 1974: 127(May): 676–81
- Khan MA, Khan MK. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 1982: 96(1): 70–6
- Agnello V. Immune complex assays in rheumatic diseases. Hum Pathol 1983: 14(4): 343–9
- Liang MH, Fries JF. Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis. (Editorial) J Rheumatol 1978: 5(3): 241–4
- Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 1982: 25(6): 601–11
- Austin HA 3d, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983: 75(3): 382–91
- Fries JF, Porta J, Liang MH. Marginal benefit of renal biopsy in systemic lupus erythematosus. Arch Intern Med 1978: 138(9): 1386–9
- Liang MH, Fries JF. Asymptomatic hyperuricemia: the case for conservative management. Ann Intern Med 1978: 88(5): 666–70